Skip to main content
. 2018 May 18;10(2):147–152. doi: 10.4274/jcrpe.5117

Figure 3. Comparison of the daily insulin dose between the two treatment groups during the five year follow-up period CSII: continuous subcutaneous insulin infusion, MDI: multiple daily insulin.

Figure 3